Company Profile

TomoTherapy Inc
Profile last edited on: 11/25/2015      CAGE: 4ANE0      UEI: TWBRPJ7ZWH64

Business Identifier: Radiation therapy system for the treatment of various types of cancers
Year Founded
1997
First Award
1998
Latest Award
2004
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1240 Deming Way
Madison, WI 53717
   (608) 824-2800
   info@tomotherapy.com
   www.tomotherapy.com
Location: Single
Congr. District: 02
County: Dane

Public Profile

In March 2011, TomoTherapy Inc was acquired by previousl SBIR-involved firm Accuray. TomoTherapy develops radiotherapy devices that are designed to locate specific sites for radiation treatments for cancers, with minimal damage to surrounding tissues. A spin out from the University of Wisconsin Madison, TomoTherapy develops, manufactures, and sells the Hi-Art system, a radiation therapy system for the treatment of various types of cancers. The Hi-Art system was marketed to hospitals and cancer treatment centers in North America, Europe, and Asia. Tomotherapy is developing a more cost effective radiation treatment for cancer patients. The firm manufactures radiation therapy equipment designed a helical tomotherapy system to target radiation treatment on the patient's tumor while helping to limit damage as much as possible to the surrounding tissues. The system delivers intensity modulated radiotherapy (IMRT) using a multileaf collimator. IMRT involves changing the size, shape, and intensity of the radiation beam to conform to the size, shape, and location of the patient's tumor.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : TOMO
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2004 2 NIH $996,828
Project Title: Amorphous Selenium Imaging for Tomotherapy

Key People / Management

  Paul J Reckwerdt -- President

  Guang M Fang